Rigel Pharmaceuticals, Inc.
RIGL
$42.58
$1.794.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 99.79% | -96.77% | 860.81% | -53.20% | 420.82% |
| Total Depreciation and Amortization | 42.04% | -0.67% | -0.33% | -0.66% | 0.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 108.72% | 102.41% | -8,502.87% | 107.84% | -1,279.16% |
| Change in Net Operating Assets | 102.31% | -270.92% | 54.68% | -201.32% | 145.23% |
| Cash from Operations | 1,024.88% | -87.60% | -8.53% | -21.31% | 3,519.60% |
| Capital Expenditure | -- | -- | 200.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 318.85% | 68.57% | 23.49% | -42.48% | -120.58% |
| Cash from Investing | 318.85% | 68.56% | 23.55% | -42.53% | -120.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -536.67% | 0.00% | -- | -- | -- |
| Issuance of Common Stock | 480.69% | -89.04% | -31.44% | 921.77% | -13.64% |
| Repurchase of Common Stock | 86.34% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -7.16% | -138.82% | -207.05% | 921.77% | -13.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 325.15% | -103.28% | -63.23% | -163.46% | 170.06% |